US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 8.120
  • +0.020+0.25%
Close Mar 4 16:00 ET
  • 8.120
  • 0.0000.00%
Post 17:04 ET
1.21BMarket Cap-7.52P/E (TTM)

Adaptive Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
-10.08%-46.68M
49.95%-23.56M
8.22%-59.15M
Net income from continuing operations
29.16%-159.6M
51.46%-33.72M
36.22%-32.1M
3.27%-46.25M
17.62%-47.53M
-12.45%-225.3M
-72.94%-69.47M
-11.05%-50.33M
8.20%-47.81M
8.12%-57.7M
Depreciation and amortization
-13.38%19.26M
-17.51%4.45M
-20.34%4.59M
-11.50%5M
-3.85%5.21M
6.27%22.23M
2.01%5.39M
7.06%5.76M
8.82%5.65M
7.26%5.42M
Other non cash items
-35.15%8.04M
-14.45%1.86M
-49.35%1.88M
-36.73%1.93M
-31.52%2.37M
51.25%12.39M
1.68%2.17M
49.80%3.71M
68.83%3.05M
95.15%3.46M
Change In working capital
62.21%-17.45M
186.93%3.05M
30.13%-13.03M
529.40%2.83M
57.89%-10.31M
35.45%-46.18M
66.50%-3.51M
3.75%-18.65M
102.30%449K
-10.21%-24.48M
-Change in receivables
-284.25%-3.74M
86.71%-899K
-1,658.08%-5.2M
1,132.37%6.41M
-144.60%-4.05M
108.97%2.03M
49.91%-6.77M
111.78%334K
47.99%-621K
277.82%9.09M
-Change in inventory
289.29%5.37M
-14.96%3.38M
721.61%1.7M
-1,358.46%-818K
116.82%1.11M
-447.37%-2.84M
31.30%3.98M
-479.17%-273K
111.93%65K
-279.93%-6.61M
-Change in prepaid assets
104.30%83K
-52.80%960K
67.69%-1.4M
-239.00%-998K
531.82%1.52M
-154.35%-1.93M
-31.05%2.03M
-9,969.77%-4.33M
325.79%718K
-136.59%-352K
-Change in payables and accrued expense
112.41%671K
-20.13%4.26M
97.90%-59K
-94.87%407K
75.18%-3.94M
-176.04%-5.41M
-49.30%5.34M
-150.71%-2.81M
662.72%7.94M
-110.44%-15.88M
-Change in other working capital
47.85%-19.84M
42.51%-4.65M
30.31%-8.06M
71.57%-2.18M
53.89%-4.94M
37.00%-38.04M
39.95%-8.1M
47.66%-11.57M
52.21%-7.65M
-22.17%-10.72M
Cash from discontinued investing activities
Operating cash flow
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
-10.08%-46.68M
49.95%-23.56M
8.22%-59.15M
Investing cash flow
Cash flow from continuing investing activities
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
-54.95%26.14M
686.41%37.32M
67.11%62.98M
Net PPE purchase and sale
65.75%-3.66M
93.84%-80K
87.62%-344K
53.23%-1.73M
48.32%-1.51M
34.57%-10.7M
48.94%-1.3M
48.86%-2.78M
30.22%-3.7M
4.97%-2.92M
Net investment purchase and sale
-41.96%81.46M
392.76%22.2M
-80.53%5.63M
-81.46%7.61M
-30.17%46.02M
628.91%140.34M
104.74%4.51M
-54.42%28.92M
308.40%41.02M
61.67%65.9M
Cash from discontinued investing activities
Investing cash flow
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
-54.95%26.14M
686.41%37.32M
67.11%62.98M
Financing cash flow
Cash flow from continuing financing activities
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-98.30%2.25M
1,350.00%87K
-99.99%17K
-63.18%1.47M
-75.55%672K
Proceeds from stock option exercised by employees
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-71.55%2.25M
-72.98%87K
-97.95%17K
-63.18%1.47M
-75.55%672K
Cash from discontinued financing activities
Financing cash flow
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-98.30%2.25M
1,350.00%87K
-99.99%17K
-63.18%1.47M
-75.55%672K
Net cash flow
Beginning cash position
-26.43%68M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
-26.43%68M
-34.54%92.43M
-58.35%91.63M
42.23%112.16M
-17.29%96.93M
-34.54%92.43M
Current changes in cash
29.69%-17.18M
141.27%9.76M
-5.89%-21.74M
-174.80%-11.4M
37.81%6.2M
49.91%-24.43M
81.47%-23.64M
-114.55%-20.53M
139.75%15.24M
118.73%4.5M
End cash Position
-25.26%50.82M
-25.26%50.82M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
-26.43%68M
-26.43%68M
-58.35%91.63M
42.23%112.16M
-17.29%96.93M
Free cash flow
40.80%-98.88M
55.47%-12.57M
44.59%-27.41M
30.17%-19.03M
35.78%-39.86M
16.61%-167.02M
13.30%-28.23M
-3.39%-49.46M
47.95%-27.25M
8.08%-62.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M15.02%-156.32M10.28%-26.93M-10.08%-46.68M49.95%-23.56M8.22%-59.15M
Net income from continuing operations 29.16%-159.6M51.46%-33.72M36.22%-32.1M3.27%-46.25M17.62%-47.53M-12.45%-225.3M-72.94%-69.47M-11.05%-50.33M8.20%-47.81M8.12%-57.7M
Depreciation and amortization -13.38%19.26M-17.51%4.45M-20.34%4.59M-11.50%5M-3.85%5.21M6.27%22.23M2.01%5.39M7.06%5.76M8.82%5.65M7.26%5.42M
Other non cash items -35.15%8.04M-14.45%1.86M-49.35%1.88M-36.73%1.93M-31.52%2.37M51.25%12.39M1.68%2.17M49.80%3.71M68.83%3.05M95.15%3.46M
Change In working capital 62.21%-17.45M186.93%3.05M30.13%-13.03M529.40%2.83M57.89%-10.31M35.45%-46.18M66.50%-3.51M3.75%-18.65M102.30%449K-10.21%-24.48M
-Change in receivables -284.25%-3.74M86.71%-899K-1,658.08%-5.2M1,132.37%6.41M-144.60%-4.05M108.97%2.03M49.91%-6.77M111.78%334K47.99%-621K277.82%9.09M
-Change in inventory 289.29%5.37M-14.96%3.38M721.61%1.7M-1,358.46%-818K116.82%1.11M-447.37%-2.84M31.30%3.98M-479.17%-273K111.93%65K-279.93%-6.61M
-Change in prepaid assets 104.30%83K-52.80%960K67.69%-1.4M-239.00%-998K531.82%1.52M-154.35%-1.93M-31.05%2.03M-9,969.77%-4.33M325.79%718K-136.59%-352K
-Change in payables and accrued expense 112.41%671K-20.13%4.26M97.90%-59K-94.87%407K75.18%-3.94M-176.04%-5.41M-49.30%5.34M-150.71%-2.81M662.72%7.94M-110.44%-15.88M
-Change in other working capital 47.85%-19.84M42.51%-4.65M30.31%-8.06M71.57%-2.18M53.89%-4.94M37.00%-38.04M39.95%-8.1M47.66%-11.57M52.21%-7.65M-22.17%-10.72M
Cash from discontinued investing activities
Operating cash flow 39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M15.02%-156.32M10.28%-26.93M-10.08%-46.68M49.95%-23.56M8.22%-59.15M
Investing cash flow
Cash flow from continuing investing activities -40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M4,362.89%129.65M103.29%3.21M-54.95%26.14M686.41%37.32M67.11%62.98M
Net PPE purchase and sale 65.75%-3.66M93.84%-80K87.62%-344K53.23%-1.73M48.32%-1.51M34.57%-10.7M48.94%-1.3M48.86%-2.78M30.22%-3.7M4.97%-2.92M
Net investment purchase and sale -41.96%81.46M392.76%22.2M-80.53%5.63M-81.46%7.61M-30.17%46.02M628.91%140.34M104.74%4.51M-54.42%28.92M308.40%41.02M61.67%65.9M
Cash from discontinued investing activities
Investing cash flow -40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M4,362.89%129.65M103.29%3.21M-54.95%26.14M686.41%37.32M67.11%62.98M
Financing cash flow
Cash flow from continuing financing activities -89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-98.30%2.25M1,350.00%87K-99.99%17K-63.18%1.47M-75.55%672K
Proceeds from stock option exercised by employees -89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-71.55%2.25M-72.98%87K-97.95%17K-63.18%1.47M-75.55%672K
Cash from discontinued financing activities
Financing cash flow -89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-98.30%2.25M1,350.00%87K-99.99%17K-63.18%1.47M-75.55%672K
Net cash flow
Beginning cash position -26.43%68M-55.19%41.06M-44.01%62.8M-23.45%74.2M-26.43%68M-34.54%92.43M-58.35%91.63M42.23%112.16M-17.29%96.93M-34.54%92.43M
Current changes in cash 29.69%-17.18M141.27%9.76M-5.89%-21.74M-174.80%-11.4M37.81%6.2M49.91%-24.43M81.47%-23.64M-114.55%-20.53M139.75%15.24M118.73%4.5M
End cash Position -25.26%50.82M-25.26%50.82M-55.19%41.06M-44.01%62.8M-23.45%74.2M-26.43%68M-26.43%68M-58.35%91.63M42.23%112.16M-17.29%96.93M
Free cash flow 40.80%-98.88M55.47%-12.57M44.59%-27.41M30.17%-19.03M35.78%-39.86M16.61%-167.02M13.30%-28.23M-3.39%-49.46M47.95%-27.25M8.08%-62.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taiwan Semiconductor
TSM
+4.06%
Advanced Micro Devices
AMD
+2.57%
Alphabet-A
GOOGL
+2.34%
Alphabet-C
GOOG
+2.34%
NVIDIA
NVDA
+1.69%

Unlock the Full List